MED13L encodes Mediator of RNA polymerase II transcription subunit 13-like, a non-enzymatic subunit of the Mediator complex's CDK8 kinase module (CKM). The protein functions as a structural tether linking the CKM to core Mediator (cMED), regulating Pol II engagement and transcriptional programs. MED13L contains an Ago-like domain architecture with intrinsically disordered regions (IDRs) that can restrict or allow cMED interaction with Pol II/MED26, thereby modulating promoter-proximal events including initiation and pause-release. The protein localizes primarily to the nucleus and is required for Rb/E2F control of cell growth and neuronal dendritic development. Pathogenic variants cause MED13L syndrome characterized by developmental delay, intellectual disability, speech impairment, and congenital heart defects.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
| GO:0003712 transcription coregulator activity | IEA GO_REF:0000002 | ACCEPT | Summary: MED13L is a non-enzymatic subunit of the Mediator complex's CDK8 kinase module (CKM) that functions as a coregulator of transcription by RNA polymerase II. It modulates transcription through its structural/tethering role in the CKM. Deep research confirms MED13L has an Ago-like domain architecture with intrinsically disordered regions (IDRs) that regulate Pol II access to the core Mediator. Reason: This is a core molecular function of MED13L. The protein is part of the Mediator complex and directly regulates transcription as a coregulator. PMID:22249253 demonstrates that MED13L is required for Rb/E2F transcriptional control. Deep research provides structural basis for the coregulatory mechanism. Supporting Evidence: PMID:22249253 the Mediator complex subunit MED13L is required for Rb/E2F control of cell growth, the complete repression of cell cycle target genes, and cell cycle inhibition file:human/MED13L/MED13L-deep-research-falcon.md MED13L encodes Mediator of RNA polymerase II transcription subunit 13-like, a non-enzymatic subunit of the Mediator complex's cyclin-dependent kinase module (CKM) |
| GO:0005634 nucleus | IEA GO_REF:0000044 | ACCEPT | Summary: MED13L localizes primarily to the nucleus, consistent with its role as a Mediator complex subunit involved in transcription regulation by RNA polymerase II. Reason: Nuclear localization is the primary subcellular location for MED13L, consistent with its function in the Mediator complex which operates in the nucleus to regulate transcription. Deep research confirms primarily nuclear localization with additional neuronal synapse localization reported. |
| GO:0006351 DNA-templated transcription | IEA GO_REF:0000043 | ACCEPT | Summary: MED13L is involved in DNA-templated transcription as a component of the Mediator complex, which is a large multiprotein coactivator required for RNA polymerase II transcription. Reason: This is a core biological process for MED13L. The Mediator complex is central to transcription by RNA polymerase II, and MED13L is an essential subunit. Supporting Evidence: PMID:22249253 components of the Mediator complex, a large multiprotein coactivator required for RNA polymerase II transcription |
| GO:0006357 regulation of transcription by RNA polymerase II | IEA GO_REF:0000002 | ACCEPT | Summary: MED13L regulates transcription by RNA polymerase II through its tethering role in the CDK8 kinase module, which modulates Mediator-Pol II interactions and promoter-proximal events including initiation and pause-release. Reason: This is the core biological process function of MED13L. The protein regulates Pol II transcription by controlling access of Pol II to the core Mediator through its intrinsically disordered regions. Supporting Evidence: PMID:22249253 the Mediator complex subunit MED13L is required for Rb/E2F control of cell growth, the complete repression of cell cycle target genes |
| GO:0016592 mediator complex | IEA GO_REF:0000002 | ACCEPT | Summary: MED13L is definitionally a component of the Mediator complex, specifically the CDK8 kinase module (CKM) which associates with the core Mediator. The IEA annotation to the broader mediator complex term is appropriate as a general annotation. More specifically, MED13L resides in the CKM complex (GO:1990508) which reversibly associates with the core Mediator. Reason: This is a valid cellular component annotation for MED13L. The gene encodes Mediator of RNA polymerase II transcription subunit 13-like, and MED13L is a bona fide subunit of the Mediator complex. Deep research confirms MED13L as a CKM tether that links the CKM to core Mediator. While a more specific annotation to CKM complex (GO:1990508) could be added, this general annotation remains correct. Supporting Evidence: PMID:22249253 components of the Mediator complex, a large multiprotein coactivator required for RNA polymerase II transcription file:human/MED13L/MED13L-deep-research-falcon.md Member of Mediator CDK8 kinase module (CKM) paralog set MED12/12L, MED13/13L, CDK8/19, cyclin C; MED13L (paralog of MED13) tethers CKM to core Mediator and can modulate Pol II access |
| GO:0003713 transcription coactivator activity | IDA PMID:22249253 A role for Mediator complex subunit MED13L in Rb/E2F-induced... | ACCEPT | Summary: PMID:22249253 demonstrated through a genome-wide shRNA screen that MED13L is required for Rb/E2F-mediated transcriptional control. The study showed that MED13L is essential for both transcriptional activation and repression of cell cycle target genes. Reason: This is supported by direct experimental evidence from PMID:22249253. While the Mediator complex can function in both activation and repression, the coactivator function is a well-established aspect of Mediator biology. Supporting Evidence: PMID:22249253 components of the Mediator complex, a large multiprotein coactivator required for RNA polymerase II transcription |
| GO:0045944 positive regulation of transcription by RNA polymerase II | IDA PMID:22249253 A role for Mediator complex subunit MED13L in Rb/E2F-induced... | ACCEPT | Summary: PMID:22249253 demonstrated that MED13L is required for proper regulation of cell cycle target genes. As a Mediator complex subunit, MED13L contributes to positive regulation of transcription through the coactivator function of Mediator. Reason: Supported by direct experimental evidence. The Mediator complex is required for RNA polymerase II transcription, and MED13L is essential for this function. Supporting Evidence: PMID:22249253 components of the Mediator complex, a large multiprotein coactivator required for RNA polymerase II transcription |
| GO:0005654 nucleoplasm | TAS Reactome:R-HSA-9836857 | ACCEPT | Summary: The nucleoplasm localization is consistent with MED13L's role in the Mediator complex, which functions in the nucleoplasm to regulate RNA polymerase II transcription. Reason: This is a valid subcellular localization annotation. Mediator complex subunits are expected to localize to the nucleoplasm where they function in transcription regulation. |
Loading supporting content…
Download this section (compressed HTML)Q: What is the specific mechanism by which MED13L IDRs regulate Pol II access to core Mediator?
Q: How does MED13L contribute to neuronal development at the transcriptional level?
Q: Are there tissue-specific functions of MED13L beyond its general role in transcription?
Experiment: Cryo-EM structure of MED13L-containing CKM in complex with core Mediator and Pol II
Hypothesis: Structural analysis could reveal the mechanism of IDR-mediated gating of Pol II access
Experiment: ChIP-seq and RNA-seq in MED13L-deficient neurons to identify direct target genes
Hypothesis: This would reveal the transcriptional programs regulated by MED13L in neurons
Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)Loading supporting content…
Download this section (compressed HTML)